SP110
Basic information
Region (hg38): 2:230165186-230225729
Previous symbols: [ "IFI41", "IFI75" ]
Links
Phenotypes
GenCC
Source:
- hepatic veno-occlusive disease-immunodeficiency syndrome (Moderate), mode of inheritance: AR
- hepatic veno-occlusive disease-immunodeficiency syndrome (Supportive), mode of inheritance: AR
- hepatic veno-occlusive disease-immunodeficiency syndrome (Strong), mode of inheritance: AR
- hepatic veno-occlusive disease-immunodeficiency syndrome (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Hepatic venoocclusive disease with immunodeficiency | AR | Allergy/Immunology/Infectious | Mortality is high if the condition is unrecognized; interventions include intravenous immunoglobulin and infectious prophylaxis (Pneumocystis jerovici) | Allergy/Immunology/Infectious; Cardiovascular; Gastrointestinal; Neurologic | 16648851; 17510920; 22621957; 22982295 |
ClinVar
This is a list of variants' phenotypes submitted to
- Hepatic_veno-occlusive_disease-immunodeficiency_syndrome (436 variants)
- Inborn_genetic_diseases (101 variants)
- not_provided (24 variants)
- Mycobacterium_tuberculosis,_susceptibility_to (15 variants)
- SP110-related_disorder (13 variants)
- not_specified (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SP110 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000080424.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 97 | 105 | ||||
| missense | 224 | 19 | 248 | |||
| nonsense | 13 | |||||
| start loss | 1 | 1 | ||||
| frameshift | 13 | 21 | ||||
| splice donor/acceptor (+/-2bp) | 10 | |||||
| Total | 18 | 19 | 235 | 117 | 9 |
Highest pathogenic variant AF is 0.000114628165
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SP110 | protein_coding | protein_coding | ENST00000258381 | 18 | 58436 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.46e-14 | 0.745 | 125659 | 0 | 89 | 125748 | 0.000354 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.335 | 355 | 373 | 0.951 | 0.0000208 | 4695 |
| Missense in Polyphen | 24 | 23.936 | 1.0027 | 232 | ||
| Synonymous | -0.121 | 141 | 139 | 1.01 | 0.00000863 | 1307 |
| Loss of Function | 1.83 | 28 | 40.6 | 0.689 | 0.00000221 | 493 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000420 | 0.000420 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000109 | 0.000109 |
| Finnish | 0.0000924 | 0.0000924 |
| European (Non-Finnish) | 0.000220 | 0.000220 |
| Middle Eastern | 0.000109 | 0.000109 |
| South Asian | 0.00160 | 0.00160 |
| Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Transcription factor. May be a nuclear hormone receptor coactivator. Enhances transcription of genes with retinoic acid response elements (RARE).;
- Disease
- DISEASE: Hepatic venoocclusive disease with immunodeficiency (VODI) [MIM:235550]: Autosomal recessive primary immunodeficiency associated with hepatic vascular occlusion and fibrosis. The immunodeficiency is characterized by severe hypogammaglobulinemia, combined T and B-cell immunodeficiency, absent lymph node germinal centers, and absent tissue plasma cells. {ECO:0000269|PubMed:16648851}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- loftool
- 0.496
- rvis_EVS
- 0.54
- rvis_percentile_EVS
- 81.1
Haploinsufficiency Scores
- pHI
- 0.0394
- hipred
- N
- hipred_score
- 0.214
- ghis
- 0.450
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.682
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sp110
- Phenotype
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;viral process
- Cellular component
- nucleus
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding